Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia-Reference-Cited by-同舟云学术

Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia

Published:2016-06-10 Issue:9 Volume:71 Page:2646-2650
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Katlama C.,Soulié C.,Caby F.,Denis A.,Blanc C.,Schneider L.,Valantin M.-A.,Tubiana R.,Kirstetter M.,Valdenassi E.,Nguyen Thuy,Peytavin G.,Calvez V.,Marcelin A.-G.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/9/2646/6777703/dkw186.pdf

Reference23 articles.

1. Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study

2. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

3. European AIDS Clinical Society . EACS Guidelines, Version 8.0, October 2015 . http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html .

4. AIDSinfo. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents . https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0 .

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings;Viruses;2023-12-14

2. Mutation Patterns of Integrase Gene Affect Antiretroviral Resistance in Various non-B Subtypes of Human Immunodeficiency Virus Type-1 and Their Implications for Patients’ Therapy;BioMedicine;2023-11-27

3. Dynamics of Human Immunodeficiency Virus Type 1 A6 Variant Transmissions Between Poland and Ukraine;Clinical Infectious Diseases;2023-02-28

4. HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa;Journal of Antimicrobial Chemotherapy;2022-04-27

5. Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study;Antimicrobial Agents and Chemotherapy;2022-01-18